Cargando…
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is characterised by fat accumulation in the liver (hepatic steatosis) with varying degrees of inflammation and fibrosis...
Autores principales: | Keating, Shelley E., Sabag, Angelo, Hallsworth, Kate, Hickman, Ingrid J., Macdonald, Graeme A., Stine, Jonathan G., George, Jacob, Johnson, Nathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687186/ https://www.ncbi.nlm.nih.gov/pubmed/37695493 http://dx.doi.org/10.1007/s40279-023-01918-w |
Ejemplares similares
-
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
por: Heinle, James Westley, et al.
Publicado: (2023) -
The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review
por: Johnston, Heidi E., et al.
Publicado: (2022) -
Effect of aerobic exercise on waist circumference in adults with overweight or obesity: A systematic review and meta‐analysis
por: Armstrong, Alex, et al.
Publicado: (2022) -
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
por: Zhou, Xiao-Dong, et al.
Publicado: (2023) -
The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
por: Memon, Iqbal A., et al.
Publicado: (2023)